CRISPR Journal

Papers
(The median citation count of CRISPR Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Will Advances in Genetic Medicine Lessen the Need for Germline Modifications?508
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions52
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types51
Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator42
Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes41
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient40
CRISPR Comparison Toolkit: Rapid Identification, Visualization, and Analysis of CRISPR Array Diversity38
Inference of CRISPR Edits from Sanger Trace Data33
A Taxonomic and Phylogenetic Classification of Diverse Base Editors32
Gene Editing and Rett Syndrome: Does It Make the Cut?32
Opposing Human Genetic Engineering30
Curing “GFP-itis” in Bacteria with Base Editors: Development of a Genome Editing Science Program Implemented with High School Biology Students29
Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection28
Acknowledgment of Reviewers 202228
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering24
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas24
The Lexicon of CRISPR: When Is It Too Much?23
Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods22
Efficient Installation of Heterozygous Mutations in Human Pluripotent Stem Cells Using Prime Editing22
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG21
The Roles and Responsibilities of Scientific Journals in Research Governance: Editorial Policymaking at Nature and Springer Nature (1995–2023)18
CRISPR Crops and Sustainable Agriculture18
Implementing CRISPR-Cas9 Yeast Practicals into Biology Curricula18
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing17
Comprehensive Analysis of CRISPR-Cas9 Editing Outcomes in Yeast Xanthophyllomyces dendrorhous17
Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors16
CRISPR Rewrites the Future of Medicine15
CRISPR à la carte15
A Story of Perseverance: An Interview with Matthew Porteus14
Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements13
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer13
CRISPR-Cas9 Single Nucleotide Editing of Tuberous Sclerosis Complex 2 Gene in Mesenchymal Stem Cells13
Engineering CjCas9 for Efficient Base Editing and Prime Editing13
Institutional Bioethics: From Critical Interdisciplinarity to Cosmopolitanism12
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies12
Widespread Impact of Natural Genetic Variations in CRISPR-Cas9 Outcomes12
Engineered Antiviral Sensor Targets Infected Mosquitoes11
Rational Engineering of CRISPR-Cas9 Nuclease to Attenuate Position-Dependent Off-Target Effects11
Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 111
Combined Theoretical, Bioinformatic, and Biochemical Analyses of RNA Editing by Adenine Base Editors11
CRISPR Momentum in the Clinic and the Field11
Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control11
Enhancements of the CRISPR-Cas System in the Silkworm Bombyx mori10
A PCR-Induced Mutagenesis-Restriction Fragment Length Polymorphism Method for the Detection of CRISPR-Induced Indels10
Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative10
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance10
Efficient CRISPR-Cas9-Mediated Genome Editing of the Cane Toad (Rhinella marina)10
A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors10
Cas12a-Capture: A Novel, Low-Cost, and Scalable Method for Targeted Sequencing9
The CRISPR Revolution in the Drug Discovery Workflow: An Industry Perspective9
Fanzors: Mysterious TnpB-Like Bacterial Transposon-Related RNA-Guided DNA Nucleases of Eukaryotes9
Warrior Spirit: An Interview with Victoria Gray, Sickle Cell Pioneer9
A Protein-Cutting CRISPR Complex Caught in Action9
It's a Knockout for Cat Allergies?9
Introducing Faith-Based Claims to Ethical Discourse on Scientific Matters8
Bacterial Retrons Enable Precise Gene Editing in Human Cells8
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas138
Five Years of Progress in CRISPR Clinical Trials (2019–2024)7
Acknowledgment of Reviewers 20237
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo7
Moving Therapeutic Genome Editing into Global Clinical Trials and Medicine7
Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification7
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 27
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects7
Genome Editing Headwinds: Can CRISPR Stay on Target?7
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells7
Navigating Viral Space with CRISPR Technologies7
Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts7
The New Old Colonialism7
Base Editing of Somatic Cells Using CRISPR–Cas9 in Drosophila7
Special Issue: Manipulating the Microbiome with CRISPR6
Bio-Orthogonal Chemistry Conjugation Strategy Facilitates Investigation of N-methyladenosine and Thiouridine Guide RNA Modifications on CRISPR Activity6
Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs6
Correction to: APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels by Rieffer et al. The CRISPR Journal, 2023;6(5):430–446; DOI: 10.1089/crispr.2023.00276
Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities6
Correction to: Give Cas a Chance: An Actionable Path to a Platform for CRISPR Cures, by Fyodor D. Urnov [DOI: 10.1089/crispr.2024.0082]6
Characterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials6
Special Issue: CRISPR Trials6
Extreme Genome Editing6
PASTE: The Way Forward for Large DNA Insertions5
A Reset for Bioethics: A Statement from the Global Observatory for Genome Editing5
An Efficient and Cost-Effective Novel Strategy for Identifying CRISPR-Cas-Mediated Mutants in Plant Offspring5
Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing5
Celebrating a Decade of CRISPR-Fueled Genome Editing5
CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus5
Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes5
CRISPR-Cas9 Long-Read Sequencing for Mapping Transgenes in the Mouse Genome5
Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic5
Recalibrating Health Governance, Equity, and Reproductive Rights in India: A Case Study from the Global South5
Facing Systemic Uncertainty, Can the CRISPR Community Stay the Course?5
Introducing Perspectives from the Global Observatory for Genome Editing4
A Phage Variable Region Encodes Anti-CRISPR Proteins Inhibiting All Streptococcus thermophilus CRISPR Immune Systems4
Correction to: Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells by Zhang et al. The CRISP4
Green Fluorescent Protein Tagged Polycistronic Reporter System Reveals Functional Editing Characteristics of CRISPR-Cas4
Discovery and Characterization of Novel Type V Cas12f Nucleases with Diverse Protospacer Adjacent Motif Preferences4
Enhanced Myogenesis by Silencing Myostatin with Nonviral Delivery of a dCas9 Ribonucleoprotein Complex4
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels4
Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications4
Science with Society at Science Gallery Bengaluru4
Predicting Mutations Generated by Cas9, Base Editing, and Prime Editing in Mammalian Cells4
Toward a Global Deliberative System for Genome Editing4
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability4
Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays4
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model4
Genetic Manipulation of a CAST of Characters in a Microbial Community4
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells4
Response to Cook et al. re: Novel Off-Targeting Events Identified After Genome Wide Analysis of CRISPR-Cas Edited Pig4
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa4
Genomic and Transcriptomic Analyses of Prime Editing Guide RNA–Independent Off-Target Effects by Prime Editors3
Identification of a Guide RNA Targeting an Ultraconserved Element for Evaluation of Cas9 Genome Editors Across Mammalian Species3
AI and SynBio Meet CRISPR Heralding a New Genome Editing Era3
A “Bare Hope of A Result”: The Second CRISPR Patent Appeal3
Acknowledgment of Reviewers 20213
Correction to: Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas by Burger et al. The CRISPR Journal,3
CRISPR-Cas9 Genome Editing Uncovers the Mode of Action of Methoprene in the Yellow Fever Mosquito, Aedes aegypti3
Genome Editing in Apicomplexan Parasites: Current Status, Challenges, and Future Possibilities3
Special Issue on CRISPR Diagnostics3
Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides3
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies3
CRISPR Empowers Tree Bioengineering for a Sustainable Future2
The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells2
Compact Cje3Cas9 for Efficient In Vivo Genome Editing and Adenine Base Editing2
Establishment of a CRISPR-Cas9-Mediated Genome Editing System in Flax2
Optimizing Genome Editing in Mollusks (Crassostrea gigas) in Vitro Validation of sgRNA and Identifying Key Factors Influencing Efficiency2
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for The CRISPR Journal2
Search for Origins of Anti-CRISPR Proteins by Structure Comparison2
Advances in Gene Therapy for Sickle Cell Disease: From Preclinical Innovations to Clinical Implementation and Access Challenges2
JACKIE: Fast Enumeration of Genome-Wide Single- and Multicopy CRISPR Target Sites and Their Off-Target Numbers2
Periodontal Disease Pathogens, Pathogenesis, and Therapeutics: The CRISPR-Cas Effect2
Monitoring the Land and Sea: Enhancing Efficiency Through CRISPR-Cas Driven Depletion and Enrichment of Environmental DNA2
Model System to Analyze RNA-Mediated DNA Repair in Mammalian Cells2
Functional and Phylogenetic Diversity of Cas10 Proteins2
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas92
Special Issue: Manipulating the Microbiome with CRISPR2
Highly Efficient One-Step Tagging of Endogenous Genes in Primary Cells Using CRISPR-Cas Ribonucleoproteins2
Biotechnologies in the World: On Global Asymmetries and the Need for Cosmopolitanism2
CRISPR's Path to the Clinic2
Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells2
CRISPR and the Plant Pathologists' Holy Grail2
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy2
0.11662292480469